Optimal target localization for subthalamic stimulation in patients with Parkinson disease

Neurology

Volumn 82, Issue 15, 2014, Pages 1352-1361

  Welter, Marie Laure ^a,b,c,d   Schüpbach, Michael ^a,b,c,d,e   Czernecki, Virginie ^a,b,d   Karachi, Carine ^a,b,c,d   Fernandez Vidal, Sara ^a,b,c,d   Golmard, Jean Louis ^a,d   Serra, Giulia ^d   Navarro, Soledad ^d   Welaratne, Arlette ^d   Hartmann, Andréas ^a,b,c,d   Mesnage, Valérie ^a,b,c,d   Pineau, Fanny ^a,b,c,d   Cornu, Philippe ^d   Pidoux, Bernard ^d   Worbe, Yulia ^a,b,c,d   Zikos, Panayiotis ^d,f   Grabli, David ^a,b,c,d   Galanaud, Damien ^a,b,c,d   Bonnet, Anne Marie ^d   Belaid, Hayat ^d   Dormont, Didier ^a,b,c,d   Vidailhet, Marie ^a,b,c,d   Mallet, Luc ^a,b,c   Houeto, Jean Luc ^g   Bardinet, Eric ^a,b,c   Yelnik, Jerome ^a,b,c   Agid, Yves ^a,b,c,d   more..

^a SORBONNE UNIVERSITÉ   (France)

^b INSERM   (France)

^c CNRS   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e Neurologische Universitatsklinik Bern   (Switzerland)

^f IASO GENERAL HOSPITAL   (Greece)

^g POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARKINSON AGENT; LEVODOPA;

ADULT; AGED; ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL FEATURE; COGNITION; CONFUSION; GENERATOR; HUMAN; HYPOMANIA; MAJOR CLINICAL STUDY; MICROELECTRODE; MOTOR DYSFUNCTION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PARKINSON DISEASE; POSTOPERATIVE DEPRESSION; PRIORITY JOURNAL; PSYCHOSIS; SUBTHALAMIC NUCLEUS; ZONA INCERTA; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; POSTOPERATIVE PERIOD; TREATMENT OUTCOME;

AGED; DEEP BRAIN STIMULATION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PARKINSON DISEASE; POSTOPERATIVE PERIOD; SUBTHALAMIC NUCLEUS; TREATMENT OUTCOME;

EID: 84902195847     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000000315     Document Type: Article

References (40)

1. Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N Engl J Med 1998; 339: 1105-1111. (Pubitemid 28465758)
2. Parsons TD, Rogers SA, Braaten AJ, Woods SP, Troster AI. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis. Lancet Neurol 2006; 5: 578-588. (Pubitemid 43867425)
3. Voon V, Kubu C, Krack P, Houeto JL, Troster AI. Deep brain stimulation: neuropsychological and neuropsychiatric issues. Mov Disord 2006; 21(suppl 14):S305-S327. (Pubitemid 44028289)
4. Williams A, Gill S, Varma T, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol 2010; 9: 581-591.
5. Daniels C, Krack P, Volkmann J, et al. Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable? Mov Disord 2011; 26: 2516-2521.
6. Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010; 362: 2077-2091.
7. Odekerken VJ, van Laar T, Staal MJ, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS Study): a randomised controlled trial. Lancet Neurol 2013; 12: 37-44.
8. Plaha P, Ben-Shlomo Y, Patel NK, Gill SS. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism. Brain 2006; 129: 1732-1747. (Pubitemid 43999407)
9. Welter ML, Houeto JL, Tezenas du Montcel S, et al. Clinical predictive factors of subthalamic stimulation in Parkinson's disease. Brain 2002; 125: 575-583. (Pubitemid 34194412)
10. Bonneville F, Welter ML, Elie C, et al. Parkinson disease, brain volumes, and subthalamic nucleus stimulation. Neurology 2005; 64: 1598-1604. (Pubitemid 40617698)
11. Mallet L, Schupbach M, N'Diaye K, et al. Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. Proc Natl Acad Sci USA 2007; 104: 10661-10666. (Pubitemid 47185721)
12. Ulla M, Thobois S, Llorca PM, et al. Contact dependent reproducible hypomania induced by deep brain stimulation in Parkinson's disease: clinical, anatomical and functional imaging study. J Neurol Neurosurg Psychiatry 2011; 82: 607-614.
13. Derost PP, Ouchchane L, Morand D, et al. Is DBS-STN appropriate to treat severe Parkinson disease in an elderly population? Neurology 2007; 68: 1345-1355. (Pubitemid 46659085)
14. York MK, Wilde EA, Simpson R, Jankovic J. Relationship between neuropsychological outcome and DBS surgical trajectory and electrode location. J Neurol Sci 2009; 287: 159-171.
15. Mann JM, Foote KD, Garvan CW, et al. Brain penetration effects of microelectrodes and DBS leads in STN or GPi. J Neurol Neurosurg Psychiatry 2009; 80: 794-797.
16. Saint-Cyr JA, Hoque T, Pereira LC, et al. Localization of clinically effective stimulating electrodes in the human subthalamic nucleus on magnetic resonance imaging. J Neurosurg 2002; 97: 1152-1166. (Pubitemid 35253553)
17. McClelland S III, Ford B, Senatus PB, et al. Subthalamic stimulation for Parkinson disease: determination of electrode location necessary for clinical efficacy. Neurosurg Focus 2005; 19: E12.
18. Hilliard JD, Frysinger RC, Elias WJ. Effective subthalamic nucleus deep brain stimulation sites may differ for tremor, bradykinesia and gait disturbances in Parkinson's disease. Stereotact Funct Neurosurg 2011; 89: 357-364.
19. Bejjani BP, Dormont D, Pidoux B, et al. Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg 2000; 92: 615-625. (Pubitemid 30180666)
20. Pillon B. Neuropsychological assessment for management of patients with deep brain stimulation. Mov Disord 2002; 17(suppl 3):S116-S122. (Pubitemid 36049959)
21. Schmidt R, Freidl W, Fazekas F, et al. The Mattis Dementia Rating Scale: normative data from 1,001 healthy volunteers. Neurology 1994; 44: 964-966. (Pubitemid 24158821)
22. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979; 134: 382-389. (Pubitemid 9136500)
23. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The MiniInternational Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59(suppl 20): 22-33. (Pubitemid 29001829)
24. Yelnik J, Bardinet E, Dormont D, et al. A three-dimensional, histological and deformable atlas of the human basal ganglia: I: atlas construction based on immunohistochemical and MRI data. Neuroimage 2007; 34: 618-638. (Pubitemid 44834474)
25. Bardinet E, Bhattacharjee M, Dormont D, et al. A three-dimensional histological atlas of the human basal ganglia: II: atlas deformation strategy and evaluation in deep brain stimulation for Parkinson disease. J Neurosurg 2009; 110: 208-219.
26. Haynes WI, Haber SN. The organization of prefrontal-subthalamic inputs in primates provides an anatomical substrate for both functional specificity and integration: implications for basal ganglia models and deep brain stimulation. J Neurosci 2013; 33: 4804-4814.
27. Frankemolle AM, Wu J, Noecker AM, et al. Reversing cognitive-motor impairments in Parkinson's disease patients using a computational modelling approach to deep brain stimulation programming. Brain 2010; 133: 746-761.
28. Lambert C, Zrinzo L, Nagy Z, et al. Confirmation of functional zones within the human subthalamic nucleus: patterns of connectivity and sub-parcellation using diffusion weighted imaging. Neuroimage 2012; 60: 83-94.
29. Ferraye MU, Debu B, Fraix V, et al. Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain 2010; 133: 205-214.
30. Mallet L, Polosan M, Jaafari N, et al. Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. N Engl J Med 2008; 359: 2121-2134.
31. Houeto JL, Welter ML, Bejjani PB, et al. Subthalamic stimulation in Parkinson disease: intraoperative predictive factors. Arch Neurol 2003; 60: 690-694.
32. Hamel W, Fietzek U, Morsnowski A, et al. Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: evaluation of active electrode contacts. J Neurol Neurosurg Psychiatry 2003; 74: 1036-1046.
33. Zaidel A, Spivak A, Grieb B, Bergman H, Israel Z. Subthalamic span of beta oscillations predicts deep brain stimulation efficacy for patients with Parkinson's disease. Brain 2010; 133: 2007-2021.
34. Li Q, Ke Y, Chan DC, et al. Therapeutic deep brain stimulation in parkinsonian rats directly influences motor cortex. Neuron 2012; 76: 1030-1041.
35. Rodriguez-Oroz MC, Rodriguez M, Guridi J, et al. The subthalamic nucleus in Parkinson's disease: somatotopic organization and physiological characteristics. Brain 2001; 124: 1777-1790. (Pubitemid 32845439)
36. Tsai ST, Lin SH, Lin SZ, Chen JY, Lee CW, Chen SY. Neuropsychological effects after chronic subthalamic stimulation and the topography of the nucleus in Parkinson's disease. Neurosurgery 2007; 61: E1024-E1029.
37. Lefaucheur R, Derrey S, Martinaud O, et al. Early verbal fluency decline after STN implantation: is it a cognitive microlesion effect? J Neurol Sci 2012; 321: 96-99.
38. Okun MS, Fernandez HH, Wu SS, et al. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol 2009; 65: 586-595.
39. Weintraub D, Koester J, Potenza MN, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010; 67: 589-595.
40. Cummings JL. Depression and Parkinson's disease: a review. Am J Psychiatry 1992; 149: 443-454.